Mereo BioPharma Group plc American Depositary Shares (MREO) Stock Price

MREOStock

$0.28−82.97%52W

Market Cap$44.97M

P/E—

PEG Ratio—

Div yield—

Beta0.20

MREO Share Price Chart

Favorite Metrics

Price vs S&P 500 (26W)-42.48%

Price vs S&P 500 (4W)-9.48%

VGM Score52.72

Book Value / Share (Quarterly)$0.04

P/TBV (Annual)9.00x

Indicated Dividend (Annual)$0.00

Cash Flow / Share (Quarterly)$0.01

Price vs S&P 500 (YTD)-42.48%

EPS (TTM)$-0.05

10-Day Avg Trading Volume18.24M

EPS Excl Extra (TTM)$-0.05

EPS (Annual)$-0.05

ROI (Annual)-65.04%

Gross Margin (Annual)73.40%

Cash / Share (Quarterly)$0.05

ROA (Last FY)-56.62%

EBITD / Share (TTM)$-0.05

ROE (5Y Avg)-50.82%

Cash Flow / Share (Annual)$-0.04

P/B Ratio1.42x

P/B Ratio (Quarterly)1.55x

Net Income / Employee (Annual)$-1,073,800

Net Interest Coverage (TTM)-8.46x

ROA (TTM)-72.88%

EV / EBITDA (TTM)0.08x

EPS Incl Extra (Annual)$-0.05

Current Ratio (Annual)5.40x

Quick Ratio (Quarterly)6.32x

3-Month Avg Trading Volume4.53M

52-Week Price Return-82.97%

Revenue / Employee (TTM)$0

Tangible BV / Share (Quarterly)$0.04

P/S Ratio (Annual)96.70x

Asset Turnover (Annual)0.15x

52-Week High$2.37

EPS Excl Extra (Annual)$-0.05

CapEx CAGR (5Y)91.99%

26-Week Price Return-31.24%

Quick Ratio (Annual)5.38x

13-Week Price Return6.39%

Total Debt / Equity (Annual)0.09x

Current Ratio (Quarterly)6.48x

Enterprise Value$12.13M

Revenue / Employee (Annual)$12,800

Pretax Margin (Annual)-8375.60%

Cash / Share (Annual)$0.09

3-Month Return Std Dev81.31%

Net Income / Employee (TTM)$-1,076,700

ROE (Last FY)-70.94%

Net Interest Coverage (Annual)-1.79x

EPS Basic Excl Extra (Annual)$-0.05

EV / Free Cash Flow (TTM)3.00x

Total Debt / Equity (Quarterly)0.00x

EPS Incl Extra (TTM)$-0.05

ROI (TTM)-83.24%

Revenue / Share (Annual)$0.00

Tangible BV / Share (Annual)$0.08

Price vs S&P 500 (52W)-101.28%

Year-to-Date Return-30.53%

5-Day Price Return-7.51%

EPS Normalized (Annual)$-0.05

ROA (5Y Avg)-74.73%

Net Profit Margin (Annual)-8375.60%

Month-to-Date Return-15.52%

Cash Flow / Share (TTM)$-4.46

EBITD / Share (Annual)$-0.06

Operating Margin (Annual)-8021.40%

LT Debt / Equity (Annual)0.00x

P/CF (TTM)12.04x

ROI (5Y Avg)-39.82%

LT Debt / Equity (Quarterly)0.00x

EPS Basic Excl Extra (TTM)$-0.05

P/TBV (Quarterly)1.56x

P/B Ratio (Annual)8.91x

Book Value / Share (Annual)$0.08

Price vs S&P 500 (13W)3.60%

Beta0.20x

Revenue / Share (TTM)$0.00

ROE (TTM)-83.24%

52-Week Low$0.20

vGradeB

mGradeD

vgmGradeC

MREO Earnings Surprise History

Q2 25-0.01est. -0.01

Q3 25-0.01est. -0.00

Q4 25-0.01est. -0.01

Q1 26-0.01est. 0.00

Q2 26-0.01est. -0.01

MREO Analyst Recommendations

May 2026

Jun 2026

Jul 2026

Aug 2026

4.07

Industry Peers — Pharmaceuticals(571)

Symbol	Value Score	Growth Score	Momentum Score	Price
MREOMereo BioPharma Group plc American Depositary Shares	B	—	D	$0.28
LLYEli Lilly & Co.	D	B	B	$1233.66
JNJJohnson & Johnson	D	C	B	$273.14
ABBVABBVIE INC.	D	C	B	$265.79
MRKMerck & Co., Inc.	D	C	A	$156.45
NVSNovartis AG	C	C	C	$159.98
AZNAstraZeneca PLC	C	B	C	$169.66
NVONovo-Nordisk A/S	B	C	C	$48.66
ABTAbbott Laboratories	C	C	B	$116.13
PFEPfizer Inc.	C	D	C	$28.57
VRTXVertex Pharmaceuticals Inc	D	C	B	$552.85
BMYBristol-Myers Squibb Co.	B	B	B	$67.92
SNYSanofi American Depositary Shares (Each representing one-half of one ordinary share)	B	C	C	$46.02
GSKGSK plc American Depositary Shares (Each representing two Ordinary Shares)	B	C	C	$52.07
REGNRegeneron Pharmaceuticals Inc	C	C	B	$833.56
TAKTakeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock)	C	C	C	$18.35
TEVATeva Pharmaceutical Industries Limited American Depositary Shares	C	C	C	$38.10
ONCBeOne Medicines Ltd. American Depositary Shares	D	B	C	$376.37
RPRXRoyalty Pharma plc Class A Ordinary Shares	D	D	B	$62.07
ALNYAlnylam Pharmaceuticals, Inc.	D	A	D	$240.08
ZTSZOETIS INC.	B	C	D	$77.29
INSMInsmed, Inc.	F	A	C	$123.89
ROIVRoivant Sciences Ltd. Common Shares	D	F	B	$36.47
UTHRUnited Therapeutics Corp	C	C	C	$518.53
GMABGenmab A/S ADS	C	C	B	$34.36
VTRSViatris Inc. Common Stock	B	C	B	$16.72
JAZZJazz Pharmaceuticals, Inc.	B	C	B	$260.23
ASNDAscendis Pharma A/S Ordinary Share	D	A	C	$252.99
BBIOBridgeBio Pharma, Inc. Common Stock	F	A	B	$80.40
CORTCorcept Therapeutics Inc.	F	C	A	$123.57
BMRNBioMarin Pharmaceuticals Inc	C	C	C	$66.12
ARWRArrowhead Research Corporation	D	A	B	$88.88
ELANElanco Animal Health Incorporated Common Stock	C	B	B	$25.09
MDGLMadrigal Pharmaceuticals, Inc. Common Stock	D	A	C	$512.16
CYTKCytokinetics Inc.	F	D	B	$77.46
AXSMAxsome Therapeutics, Inc	D	B	C	$205.48
SMMTSummit Therapeutics Inc. Common Stock	F	—	D	$13.36
IONSIonis Pharmaceuticals, Inc. Common Stock	D	D	C	$63.57
ABVXAbivax SA American Depositary Shares	—	—	C	$117.93
RDYDr. Reddy's Laboratories Limited American Depositary Shares	D	D	C	$12.34
PRAXPraxis Precision Medicines, Inc. Common Stock	F	—	B	$368.02
NUVLNuvalent, Inc. Class A Common Stock	—	—	B	$123.96
PTGXProtagonist Therapeutics, Inc	F	B	A	$150.59
SYRESpyre Therapeutics, Inc. Common Stock	—	—	A	$107.36
CRNXCrinetics Pharmaceuticals, Inc.	F	A	A	$84.86
TGTXTG Therapeutics, Inc.	D	B	A	$55.42
ALKSAlkermes Inc. plc	D	C	B	$49.21
RYTMRhythm Pharmaceuticals, Inc. Common Stock	F	B	C	$113.35
ORKAOruka Therapeutics, Inc. Common Stock	F	—	A	$101.82
BLTEBelite Bio, Inc American Depositary Shares	—	—	B	$161.68
COGTCogent Biosciences, Inc. Common Stock	F	—	B	$36.80

About Mereo BioPharma Group plc American Depositary Shares

Mereo BioPharma is a UK-based biopharmaceutical company developing treatments for rare genetic disorders. Its lead candidates are setrusumab for osteogenesis imperfecta and alvelestat for alpha-1 antitrypsin deficiency-related lung disease, both in late-stage clinical development.